AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Long term liabilities

Annual long term liabilities:

$463.00K-$1.52M(-76.62%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMLX annual total long term liabilities is $463.00 thousand, with the most recent change of -$1.52 million (-76.62%) on December 31, 2024.
  • During the last 3 years, AMLX annual long term liabilities has fallen by -$238.92 million (-99.81%).
  • AMLX annual long term liabilities is now -99.81% below its all-time high of $239.39 million, reached on December 31, 2021.

Performance

AMLX Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

quarterly long term liabilities:

$5.30M+$4.97M(+1519.88%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX quarterly total long term liabilities is $5.30 million, with the most recent change of +$4.97 million (+1519.88%) on June 1, 2025.
  • Over the past year, AMLX quarterly long term liabilities has increased by +$4.53 million (+586.14%).
  • AMLX quarterly long term liabilities is now -97.79% below its all-time high of $239.39 million, reached on December 31, 2021.

Performance

AMLX quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

AMLX Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-76.6%+586.1%
3 y3 years-99.8%+0.2%
5 y5 years-98.1%-92.8%

AMLX Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-99.8%at lowat high+1519.9%
5 y5-year-99.8%at low-97.8%+1519.9%
alltimeall time-99.8%at low-97.8%+1519.9%

AMLX Long term liabilities History

DateAnnualQuarterly
Jun 2025
-
$5.30M(+1519.9%)
Mar 2025
-
$327.00K(-29.4%)
Dec 2024
$463.00K(-76.6%)
$463.00K(-22.2%)
Sep 2024
-
$595.00K(-22.9%)
Jun 2024
-
$772.00K(-44.1%)
Mar 2024
-
$1.38M(-30.2%)
Dec 2023
$1.98M
$1.98M(-22.9%)
Sep 2023
-
$2.57M(-18.3%)
DateAnnualQuarterly
Jun 2023
-
$3.14M(-15.0%)
Mar 2023
-
$3.69M(-12.8%)
Dec 2022
$4.24M(-98.2%)
$4.24M(-11.1%)
Sep 2022
-
$4.77M(-9.8%)
Jun 2022
-
$5.29M(-8.6%)
Mar 2022
-
$5.79M(-97.6%)
Dec 2021
$239.39M(+225.7%)
$239.39M(+225.7%)
Dec 2020
$73.50M(+205.7%)
$73.50M
Dec 2019
$24.05M
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual total long term liabilities?
  • What is the all time high annual long term liabilities for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual total long term liabilities?

The current annual long term liabilities of AMLX is $463.00K

What is the all time high annual long term liabilities for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual total long term liabilities is $239.39M

What is Amylyx Pharmaceuticals, Inc. annual long term liabilities year-on-year change?

Over the past year, AMLX annual total long term liabilities has changed by -$1.52M (-76.62%)

What is Amylyx Pharmaceuticals, Inc. quarterly total long term liabilities?

The current quarterly long term liabilities of AMLX is $5.30M

What is the all time high quarterly long term liabilities for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $239.39M

What is Amylyx Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?

Over the past year, AMLX quarterly total long term liabilities has changed by +$4.53M (+586.14%)
On this page